Cite
HARVARD Citation
Anderson, K. et al. (2020). Filgotinib, a JAK1 Inhibitor, Has No Effect on QT Interval in Healthy Subjects. Clinical pharmacology in drug development. 9 (1), pp. 32-40. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Anderson, K. et al. (2020). Filgotinib, a JAK1 Inhibitor, Has No Effect on QT Interval in Healthy Subjects. Clinical pharmacology in drug development. 9 (1), pp. 32-40. [Online].